Skip to main content

Cambridge's Akcea rebounds with FDA approval of first drug

The company had another drug rejected by the FDA in August.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.